NDC properties for "Cyltezo 40 MG per 0.4 ML Auto-Injector" (RxCUI 2680750)
About this data
The tables show NDC propoerties for Cyltezo 40 MG per 0.4 ML Auto-Injector with the RxCUI 2680750
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Cyltezo 40 MG per 0.4 ML Auto-Injector (RxCUI 2680750)
| BLA | BLA761058 |
|---|---|
| MMSL_CODE | BD40586 |
| RxCUI | 2680750 |
| SPL_SET_ID | 115ea79b-7209-7f19-b35d-36ec0828fbf5 |
| Prescribable Synonym | CYLTEZO 40 MG in 0.4 ML Auto-Injector |
| RXNAV_STR | Cyltezo 40 MG per 0.4 ML Auto-Injector |
| RxNorm Name | 0.4 ML adalimumab-adbm 100 MG/ML Auto-Injector [Cyltezo] |
| RxNorm Synonym | Cyltezo 40 MG per 0.4 ML Auto-Injector |
| Related queries | Interactions (for RxCUI 2680750) |
NDC Properties
NDC Item 00597049547
| NDC 9 | 0597-0495 |
|---|---|
| NDC 10 | 0597-0495-47 |
| NDC Item | 00597049547 |
| Packaging | 1 KIT in 1 CARTON (0597-0495-47) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0490-32) / .4 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0495 |
NDC Item 00597049550
| NDC 9 | 0597-0495 |
|---|---|
| NDC 10 | 0597-0495-50 |
| NDC Item | 00597049550 |
| Packaging | 2 KIT in 1 CARTON (0597-0495-50) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0490-32) / .4 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0495 |
NDC Item 00597049547
| NDC 9 | 0597-0495 |
|---|---|
| NDC 10 | 0597-0495-47 |
| NDC Item | 00597049547 |
| Packaging | 1 KIT in 1 CARTON (0597-0495-47) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0490-32) / .4 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0495 |
NDC Item 00597049550
| NDC 9 | 0597-0495 |
|---|---|
| NDC 10 | 0597-0495-50 |
| NDC Item | 00597049550 |
| Packaging | 2 KIT in 1 CARTON (0597-0495-50) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0490-32) / .4 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| FDA SPL set id | 784444 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0495 |